Atypical Pneumonia (Mycoplasma, Chlamydia, Legionella)

“Atypical” = Clinical Pattern, Not Organism

Describes presentation (insidious, milder/disproportionate constitutional symptoms, NO beta-lactam response) — CONTRAST typical pneumococcal lobar pneumonia (see Strep Pharyngitis/Pneumonia topic). 3 organisms (taxonomically unrelated) share: NO conventional peptidoglycan wall susceptible to beta-lactams.

• Mycoplasma: NO cell wall at all
• Chlamydophila: atypical, peptidoglycan-poor wall
• Legionella: TRUE Gram-negative wall but intracellular, stains poorly (diagnostic outlier, not treatment-mechanism outlier) → macrolides/tetracyclines/fluoroquinolones (NOT penicillins/cephalosporins) = standard across all 3.

Mycoplasma pneumoniae

SMALLEST free-living organism, NO cell wall (see Bacterial Morphology topic). “Fried-egg” colonies on specialized media.

Clinical: “WALKING PNEUMONIA” — mild insidious course, CXR can look disproportionately severe vs how well patient appears. Adolescents/young adults, outbreak settings (barracks, dorms). Persistent dry cough, headache, low fever. Extrapulmonary (DISTINCTIVE): COLD AGGLUTININ hemolytic anemia (IgM vs I antigen, cross-reactive, hemolysis at cool peripheral temp), erythema multiforme/SJS, rare encephalitis/GBS.

Diagnosis: culture impractical (slow, specialized media). PCR + serology (incl. COLD AGGLUTININ TEST — bedside clue, blood agglutinates when cooled). Treatment: Macrolides (azithromycin) 1st line, tetracyclines alternative. Beta-lactams INEFFECTIVE (no peptidoglycan target).

Chlamydophila pneumoniae

Same family as C. trachomatis (see NGU topic — obligate intracellular, EB/RB cycle) but genetically/clinically DISTINCT. RESPIRATORY droplet (not sexual). Mild-moderate atypical pneumonia/bronchitis, outbreaks close-contact settings (schools, military). Diagnosis: PCR/serology (culture impractical like Mycoplasma). Treatment: same macrolide/tetracycline/fluoroquinolone options.

Legionella pneumophila

Fastidious, intracellular, Gram-negative. NICHE: WARM STAGNANT FRESHWATER (cooling towers, hot water tanks, fountains, spas). Transmission: INHALED AEROSOLIZED WATER, NOT person-to-person — important epidemiological/outbreak-investigation distinction from other atypicals.

Clinical — 2 DISTINCT syndromes:

• Legionnaires’ disease: severe pneumonia + disproportionate extrapulmonary features (confusion, diarrhea, hyponatremia, deranged LFTs). Elderly, smokers, immunocompromised.
• Pontiac fever: mild self-limited flu-like, NO pneumonia. Hypersensitivity-type response (not true invasion). Resolves without specific Rx.

Diagnosis: URINARY ANTIGEN TEST = standard/fast (detects serogroup 1, majority of disease). Culture: SLOW, needs BCYE (buffered charcoal yeast extract, iron+cysteine supplemented) — specialized, not routine — must SPECIFICALLY REQUEST. Treatment: Fluoroquinolones or Macrolides (azithromycin) 1st line.

Comparison Table

What “Atypical” Actually Means

“Atypical pneumonia” is a genuinely useful clinical category, but the term describes a clinical presentation pattern, not a single organism or even a single mechanism — it groups pneumonias that present more insidiously, with a milder or more disproportionate constitutional symptom picture relative to chest findings, and, critically, that do not respond to beta-lactam antibiotics, in explicit contrast to the “typical” bacterial pneumonia prototype (pneumococcal lobar pneumonia, covered under Streptococcal Pharyngitis and Pneumonia) that beta-lactams treat effectively. The organisms grouped here — Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila — are genuinely unrelated taxonomically, but share the single practical property that unifies the “atypical” label: none of them has a conventional peptidoglycan cell wall susceptible to beta-lactam action (Mycoplasma has no cell wall at all; Chlamydophila has an atypical, peptidoglycan-poor wall; Legionella, though a true Gram-negative bacterium with a normal wall, is intracellular and stains poorly with Gram stain, making it a diagnostic rather than a treatment-mechanism outlier) — which is exactly why macrolides, tetracyclines, or fluoroquinolones, not penicillins/cephalosporins, are the standard treatment across all three despite their otherwise very different biology.

Mycoplasma pneumoniae

The Organism

Mycoplasma is covered in structural depth under Bacterial Morphology and Physiology’s discussion of cell-wall-deficient organisms — it is the smallest known free-living organism, genuinely lacking a cell wall entirely (rather than merely having an atypical one), which explains both its resistance to beta-lactams (no peptidoglycan target exists at all) and its characteristic pleomorphic, “fried-egg” colony appearance on the specialized media it requires.

Clinical Manifestations

M. pneumoniae classically causes “walking pneumonia” — a genuinely descriptive term reflecting the disease’s characteristically mild, insidious course relative to chest X-ray findings that can look disproportionately severe, in patients (often adolescents/young adults, and outbreaks in close-contact settings like military barracks or college dormitories) well enough to remain ambulatory rather than acutely, severely ill. A persistent, often dry, harassing cough, headache, and low-grade fever dominate; extrapulmonary manifestations are a genuinely notable, distinctive feature of this organism specifically — cold agglutinin-mediated haemolytic anaemia (IgM antibodies against the I red-cell antigen, cross-reactive with a Mycoplasma surface component, causing agglutination and haemolysis specifically at cooler peripheral body temperatures), erythema multiforme/Stevens-Johnson syndrome, and, rarely, encephalitis or Guillain-Barré syndrome.

Diagnosis and Treatment

Culture is impractical for routine use (extremely slow, needing specialized media), so PCR and serology (including the cold agglutinin test itself, exploiting the same haemolytic mechanism above as a bedside diagnostic clue — patient blood agglutinating visibly when cooled) are the practical diagnostic approaches. Macrolides (azithromycin) are first-line treatment, with tetracyclines as an alternative — beta-lactams are entirely ineffective given the complete absence of a peptidoglycan target.

Chlamydophila pneumoniae

A respiratory pathogen from the same broader Chlamydia/Chlamydophila family covered under Non-gonococcal Urethritis (sharing that family’s obligate intracellular biology and biphasic EB/RB developmental cycle), but genetically and clinically distinct from C. trachomatis — transmitted by respiratory droplets rather than sexually, causing a mild-to-moderate atypical pneumonia or bronchitis, often in outbreaks within close-contact settings (schools, military). Diagnosis is by PCR or serology, similarly to M. pneumoniae, given comparable culture impracticality; treatment uses the same macrolide/tetracycline/fluoroquinolone options effective against the broader atypical-pneumonia group.

Legionella pneumophila

The Organism and Its Environmental Niche

Legionella is a fastidious, intracellular, Gram-negative bacillus with a genuinely distinctive environmental reservoir among respiratory pathogens: it thrives in warm, stagnant freshwater environments — cooling towers, hot water tanks/plumbing systems, decorative fountains, and whirlpool spas are the classic implicated sources — and transmission is by inhaling aerosolized contaminated water, not person-to-person spread, a genuinely important epidemiological point that shapes outbreak investigation entirely differently from the other atypical pathogens (which spread respiratory-droplet, person-to-person, the way most respiratory infections do).

Clinical Manifestations

Legionella infection produces two genuinely distinct clinical syndromes from the same organism: Legionnaires’ disease — a severe, potentially fatal pneumonia, with a disproportionate burden of extrapulmonary features (confusion, diarrhoea, and characteristic laboratory findings including hyponatraemia and deranged liver function) alongside the pulmonary picture, more common in the elderly, smokers, and the immunocompromised; and Pontiac fever — a milder, self-limited, flu-like illness without pneumonia at all, thought to represent a hypersensitivity-type response to the organism rather than genuine tissue invasion, resolving without specific treatment.

Diagnosis and Treatment

Urinary antigen testing is the standard, fast, practical diagnostic method for Legionnaires’ disease (detecting a specific Legionella serogroup 1 antigen, which accounts for the large majority of clinical disease, in urine) — genuinely useful precisely because Legionella is difficult and slow to culture, requiring a specialized medium (buffered charcoal yeast extract, BCYE, supplemented with the iron and cysteine the organism specifically requires) not used for routine respiratory specimen culture, meaning a clinician has to specifically suspect and request Legionella testing rather than expecting it to turn up on standard sputum culture. Fluoroquinolones or macrolides (azithromycin) are first-line treatment.

Comparative Summary

Multiple Choice Questions (1)